Pulmonx Corporation (LUNG)

Pulmonx Statistics

Total Valuation

Pulmonx has a market cap or net worth of $353.81 million. The enterprise value is $308.80 million.

Market Cap	353.81M
Enterprise Value	308.80M

Important Dates

The last earnings date was Wednesday, February 19, 2025, after market close.

Earnings Date	Feb 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Pulmonx has 39.49 million shares outstanding. The number of shares has increased by 2.99% in one year.

Current Share Class	39.49M
Shares Outstanding	39.49M
Shares Change (YoY)	+2.99%
Shares Change (QoQ)	+0.78%
Owned by Insiders (%)	4.25%
Owned by Institutions (%)	90.54%
Float	37.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.18
Forward PS	3.71
PB Ratio	4.13
P/TBV Ratio	4.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.58, with a Debt / Equity ratio of 0.66.

Current Ratio	5.58
Quick Ratio	4.69
Debt / Equity	0.66
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.45

Financial Efficiency

Return on equity (ROE) is -55.25% and return on invested capital (ROIC) is -23.88%.

Return on Equity (ROE)	-55.25%
Return on Assets (ROA)	-21.18%
Return on Invested Capital (ROIC)	-23.88%
Return on Capital Employed (ROCE)	-41.69%
Revenue Per Employee	$300,319
Profits Per Employee	-$202,129
Employee Count	279
Asset Turnover	0.49
Inventory Turnover	1.29

Taxes

In the past 12 months, Pulmonx has paid $500,000 in taxes.

Income Tax	500,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.82% in the last 52 weeks. The beta is 0.64, so Pulmonx's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	-37.82%
50-Day Moving Average	6.51
200-Day Moving Average	6.97
Relative Strength Index (RSI)	75.17
Average Volume (20 Days)	392,752

Short Selling Information

The latest short interest is 1.22 million, so 3.09% of the outstanding shares have been sold short.

Short Interest	1.22M
Short Previous Month	1.25M
Short % of Shares Out	3.09%
Short % of Float	3.23%
Short Ratio (days to cover)	5.56

Income Statement

In the last 12 months, Pulmonx had revenue of $83.79 million and -$56.39 million in losses. Loss per share was -$1.44.

Revenue	83.79M
Gross Profit	62.00M
Operating Income	-57.70M
Pretax Income	-57.29M
Net Income	-56.39M
EBITDA	-56.11M
EBIT	-57.70M
Loss Per Share	-$1.44

Balance Sheet

The company has $101.48 million in cash and $56.47 million in debt, giving a net cash position of $45.01 million or $1.14 per share.

Cash & Cash Equivalents	101.48M
Total Debt	56.47M
Net Cash	45.01M
Net Cash Per Share	$1.14
Equity (Book Value)	85.81M
Book Value Per Share	2.17
Working Capital	111.81M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 74.00%, with operating and profit margins of -68.87% and -67.30%.

Gross Margin	74.00%
Operating Margin	-68.87%
Pretax Margin	-66.71%
Profit Margin	-67.30%
EBITDA Margin	-66.96%
EBIT Margin	-68.87%
FCF Margin	n/a

Dividends & Yields

Pulmonx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.99%
Shareholder Yield	-2.99%
Earnings Yield	-15.94%
FCF Yield	n/a

Analyst Forecast

The average price target for Pulmonx is $11.92, which is 33.04% higher than the current price. The consensus rating is "Buy".

Price Target	$11.92
Price Target Difference	33.04%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	18.54%
EPS Growth Forecast (5Y)	-21.77%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pulmonx has an Altman Z-Score of -1.35 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.35
Piotroski F-Score	3